Amino-terminal fragments of huntingtin, which contain the expanded polyglutamine repeat, have been proposed to contribute to the pathology of Huntington's disease (HD). Data supporting this claim have been generated from patients with HD in which truncated amino-terminal fragments forming intranuclear inclusions have been observed, and from animal and cell-based models of HD where it has been demonstrated that truncated polyglutamine-containing fragments of htt are more toxic than fulllength huntingtin. We report here the identification of a region within huntingtin, spanning from amino acids 63 to 111, that is cleaved in cultured cells to generate a fragment of similar size to those observed in patients with HD. Importantly, proteolytic cleavage within this region appears dependent upon the length of the polyglutamine repeat within huntingtin, with pathological polyglutamine repeatcontaining huntingtin being more efficiently cleaved than huntingtin containing polyglutamine repeats of nonpathological size.
INTRODUCTION
Huntington's disease (HD) is a hereditable neurodegenerative disorder characterized by motor, psychiatric, and cognitive dysfunction (Gusella et al., 1996; MacDonald, 1998; Vonsattel & DiFiglia, 1998) . HD belongs to a class of neurodegenerative diseases caused by the expansion of a polyglutamine repeat in the affected protein (Ross et al., 1998; Cummings & Zoghbi, 2000) , which in HD resides within the aminoterminus of the affected protein huntingtin (htt). Polyglutamine diseases manifest when the repeat length expands beyond a certain size, which in HD is typically greater than 36 glutamines. Furthermore, there is a correlation among repeat length, disease severity, and age of onset, with earlier onset and more severe disease symptoms observed in patients with longer polyglutamine repeats (Furtado et al., 1996; Brinkman et al., 1997; Leavitt et al., 1999; Rosenblatt et al., 2001 ). These and other data support the role of the expanded polyglutamine repeat as the pathogenic moiety leading to neurodegeneration (MacDonald & Gusella, 1996) .
Evidence from human HD patients, animal models and cell-based models of HD suggests that truncated polyglutamine-containing fragments are more toxic than full-length htt (DiFiglia et al., 1997; Lunkes & Mandel, 1998; Saudou et al., 1998; Li et al., 2000) . Additionally, many studies suggest that polyglu-
